摘要
目的:评价专注达治疗儿童注意缺陷多动障碍的疗效及安全性。方法:采用前瞻、开放性、自身对照方法,对2005年7月~2006年2月就诊于该院门诊的6~14岁29例患儿采用专注达治疗6周,分别于治疗2周末、4周末及6周末通过专业量表测量、临床晤谈、体格检查、专人定期随访方式进行临床疗效和安全性评定。结果:治疗总有效率为75.9%,把各项因子于2周末、4周末、6周末与治疗前进行比较均有下降。结论:专注达是一种安全有效的治疗儿童注意缺陷多动障碍的药物。
Objective:To evaluate the efficacy and safety of concerta in treatment of attention deficit hyperactivity disorder(ADHD) in children.Methods:29 children with ADHD,aged 6~14 years,were treated by concerta for 6 weeks from July 2005 to February 2006.The assessment of efficacy and safety were detected by questionnaire,clinical examination were carried out at the time points of second,fourth,sixth weeks after treatment,respectively.Results:The effective rate of concerta in concerta group was 75.9%.The clinical indicators after treatment were lower than those before treatment.Conclusion:Concerta is an effective and safe drug in the treatment of ADHD.
出处
《中国妇幼保健》
CAS
北大核心
2009年第12期1642-1644,共3页
Maternal and Child Health Care of China
关键词
专注达
注意缺陷多动障碍
临床疗效
Concerta
Attention deficit hyperactivity disorder
Clinical efficacy